# Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

> **NCT04322734** · — · RECRUITING · sponsor: **Southwest Autism Research & Resource Center** · enrollment: 500 (estimated)

## Conditions studied

- Autism Spectrum Disorder
- Mitochondrial Pathology
- Epilepsy
- Brain Tumor
- Psychiatric Disorder
- Mitochondrial Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04322734
- **Lead sponsor:** Southwest Autism Research & Resource Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-13
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04322734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04322734, "Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04322734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*